NCT06353295

Brief Summary

The overall goal of the P4P: Peers for PrEP (pre-exposure prophylaxis) study is to pilot test a peer-led and delivered intervention for biomedical HIV prevention that is tailored to women who engage in sex work in southwestern Uganda. This study will evaluate whether this intervention is feasible, acceptable, and increases uptake of biomedical prevention.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Apr 2024Jun 2026

First Submitted

Initial submission to the registry

April 1, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 9, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

April 24, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2025

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

10 months

First QC Date

April 1, 2024

Last Update Submit

July 10, 2025

Conditions

Keywords

Biomedical HIV PreventionPeer Mentor InterventionWomen Engaged in Sex WorkUganda

Outcome Measures

Primary Outcomes (1)

  • Uptake of biomedical prevention

    Number of participants receiving biomedical prevention (e.g., oral pre-exposure prophylaxis \[PrEP\] or post-exposure prophylaxis \[PEP\]) divided by the number of participants

    6 months

Secondary Outcomes (2)

  • Feasibility of delivery of the P4P intervention by peers

    6 months

  • Acceptability of the P4P intervention

    6 months

Study Arms (1)

P4P intervention

OTHER

Peer-led PrEP/PEP intervention

Other: P4P intervention

Interventions

The final Peers for PrEP (P4P) intervention components were refined based on stakeholder engagement, key informant interviews, and focus group discussions. Trained peers will deliver the following intervention with remote clinician support and ongoing mentorship: pre-exposure prophylaxis (PrEP) access and refills in community/at hotspots; HIV testing, with option for HIV self-testing (HIVST); Rapid post-exposure prophylaxis (PEP) access for unplanned exposures; Family planning integration; Phone/text messaging hotline for peer support

P4P intervention

Eligibility Criteria

Age15 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale sex at birth
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Female sex at birth
  • Self-identified as commercial sex worker; exchange of sex for goods or money in last 3 months; or work or live in setting associated with sex work
  • Age \>=18 years (or mature minor \>=15 years)
  • HIV-negative by country-standard rapid testing algorithm

You may not qualify if:

  • Contraindication to country-recommended PrEP regimen per national guidelines
  • Unable or unwilling to provide informed consent
  • Participation in another HIV prevention study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Infectious Diseases Research Collaboration

Kampala, Uganda

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Catherine Koss, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: A single-arm pilot trial to evaluate a community-based, peer-led and delivered intervention to provide biomedical prevention products (e.g. pre-exposure prophylaxis \[PrEP\] and post-exposure prophylaxis \[PEP\]) for women who engage in sex work in southwestern Uganda. This study will test whether the intervention is feasible, acceptable, and increases biomedical prevention uptake.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2024

First Posted

April 9, 2024

Study Start

April 24, 2024

Primary Completion

February 14, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations